Editor’s Choice

In Case you Missed it:

Pharma & Human Health

4D pharma plc Commences Phase I/II Asthma Trial

A multicentre Phase I/II double-blind, placebo-controlled study of MRx-4DP0004 in patients with poorly controlled asthma has now commenced. The study will enrol 90 asthma patients not adequately controlled on their current inhaler maintenance therapy. Patients […]